Harmony Biosciences (HRMY) Q4 2022 Earnings Call Transcript

HRMY earnings call for the period ending December 31, 2022.

Related Keywords

United States , Americans , Jeffrey Dayno , Chris Howerton Jefferies , Corinne Jenkins Goldman Sachs , Raymond James , Graig Suvannavejh , Charles Duncan , Jeff Dayno , Charles Duncan Cantor Fitzgerald , Danielle Brill Raymond James , Corinne Jenkins , Graig Suvannavejh Mizuho , Chris Howerton , Danielle Brill , Piper Sandler , Luis Sanay , Brisebois Oppenheimer , Sandip Kapadia , Jeffrey Dierks , Francois Brisebois , David Amsellem , Fadia Needham , David Amsellem Piper Sandler , Jeff Dierks , Committee For Medicinal Products Human , Cantor Fitzgerald , European Medicines Agency , Goldman Sachs , Company Analyst , Harmony Biosciences , Harmony Bioscience , Motley Fool Stock Advisor , Stock Advisor , Medical Officer , Interim Chief Executive , Medicinal Products , Human Use , Prader Willi Syndrome , Ami Fadia ,